In vitro evaluation of actinobolin as an antibiotic for the treatment of periodontal disease.
Actinobolin was evaluated in vitro by a paper disc-agar diffusion method for inhibitory activity against mixed microbial cultures obtained from patients with periodontal disease and against pure bacterial cultures tentatively identified as strains of Bacteroides melaninogenicus, Fusobacterium fusiforme, Leptotrichia buccalis, and Veillonella parvula. Every culture tested was inhibited to some degree by actinobolin. These observations suggest that actinobolin may be effective in the treatment of periodontal disease.
D000693:Anaerobiosis; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001439:Bacteroides / Q000187:drug effects / Q000302:isolation & purification; D004352:Drug Resistance, Microbial; D005069:Evaluation Studies as Topic; D005673:Fusobacterium / Q000187:drug effects / Q000302:isolation & purification; D006088:Gram-Negative Aerobic Bacteria / Q000187:drug effects / Q000302:isolation & purification; D006801:Humans; D008826:Microbial Sensitivity Tests; D010518:Periodontitis / Q000188:drug therapy* / Q000382:microbiology; D013302:Streptomyces; D014678:Veillonella / Q000187:drug effects / Q000302:isolation & purification
D000900:Anti-Bacterial Agents